Your browser doesn't support javascript.
loading
New developments in non-exosomal and exosomal ncRNAs in coronary artery disease.
Li, Jingru; Wu, Xinyu; Ma, Haocheng; Sun, Guihu; Ding, Peng; Lu, Si; Zhang, Lijiao; Yang, Ping; Peng, Yunzhu; Fu, Jingyun; Wang, Luqiao.
Afiliación
  • Li J; Department of Cardiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
  • Wu X; Department of Cardiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
  • Ma H; Department of Cardiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
  • Sun G; Department of Cardiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
  • Ding P; Department of Cardiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
  • Lu S; Department of Cardiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
  • Zhang L; Department of Cardiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
  • Yang P; Department of Cardiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
  • Peng Y; Department of Cardiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
  • Fu J; Department of Endocrinology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
  • Wang L; Department of Cardiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
Epigenomics ; 14(21): 1355-1372, 2022 11.
Article en En | MEDLINE | ID: mdl-36514887
ncRNAs are increasingly found to play regulatory roles in coronary artery disease (CAD), and transcriptome studies offer greater advantages for controlling CAD at its source. Therefore, the authors conducted an accurate search and summary of studies on CAD and ncRNAs published in the past 3 years to analyze the main pathological mechanisms in CAD progression, aiming to provide a research basis for clinical treatment of CAD.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria Límite: Humans Idioma: En Revista: Epigenomics Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria Límite: Humans Idioma: En Revista: Epigenomics Año: 2022 Tipo del documento: Article País de afiliación: China